For nearly a decade, Solid has been a staunch supporter and a steering committee member of Parent Project Muscular Dystrophy’s (PPMD) committee dedicated to implementing newborn screening for Duchenne ...

Webinar to be held Wednesday, December 17, 2025, at 1:00 p.m. ET –SAN DIEGO, Dec. 16, 2025 (GLOBE NEWSWIRE) -- Capricor Therapeutics, Inc.

Solid Biosciences Inc. (NASDAQ:SLDB) is one of the stocks that will double in 2026. On December 4, Needham analyst Gil Blum ...

"Early screening gives every child a fair chance at timely, effective care, and it delivers families the answers and ...

Investing.com -- Solid Biosciences Inc. (NASDAQ:SLDB) stock rose 1.4% in after-hours trading Tuesday after the U.S. Department of Health and Human Services (HHS) added Duchenne muscular dystrophy to ...

Scotland’s NHS can now offer givinostat to ambulant children with Duchenne muscular dystrophy, marking a step forward in care ...

Capricor Therapeutics said Wednesday that its cell therapy significantly improved muscle and heart function in patients with ...

Solid Biosciences (SLDB) shared that the U.S. Department of Health and Human Services officially added Duchenne muscular dystrophy to the ...

Nine years after Sarepta Therapeutics’ Exondys 51 won a controversial FDA approval to treat a subset of patients with Duchenne muscular dystrophy, challenger from Massachusetts biotech Dyne ...

Find out if it’s time to ask about your child’s symptoms — and if they could be a sign of Duchenne. Duchenne muscular dystrophy — sometimes referred to simply as Duchenne — is a genetic disorder that ...

Shares quadrupled now that the company appears on track to reverse an earlier FDA rejection of what could be the first ...

STATEN ISLAND, N.Y. — In the “Big Heart” department, Executive Chef, Mike DiLeo played host to “Savor the Cause,” a cocktail-style soiree staged in Max’s Esca, the proceeds of which benefited ...